z-logo
open-access-imgOpen Access
A Novel PRPF31 Mutation in a Large Chinese Family with Autosomal Dominant Retinitis Pigmentosa and Macular Degeneration
Author(s) -
Fang Lü,
Lulin Huang,
Chuntao Lei,
Guiquan Sha,
Hong Zheng,
Xiaoqi Liu,
Yang Jy,
Yi Shi,
Ying Lin,
Bo Gong,
Xianjun Zhu,
Edmond S.K.,
Qiao Liao,
Lin He,
Jing Cheng,
Zhenglin Yang
Publication year - 2013
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0078274
Subject(s) - retinitis pigmentosa , macular degeneration , genetics , mutation , retinal degeneration , chinese family , biology , medicine , ophthalmology , gene
Purpose This study was intended to identify the disease causing genes in a large Chinese family with autosomal dominant retinitis pigmentosa and macular degeneration. Methods A genome scan analysis was conducted in this family for disease gene preliminary mapping. Snapshot analysis of selected SNPs for two-point LOD score analysis for candidate gene filter. Candidate gene PRPF31 whole exons' sequencing was executed to identify mutations. Results A novel nonsense mutation caused by an insertion was found in PRPF31 gene. All the 19 RP patients in 1085 family are carrying this heterozygous nonsense mutation. The nonsense mutation is in PRPF31 gene exon9 at chr19:54629961-54629961, inserting nucleotide “A” that generates the coding protein frame shift from p.307 and early termination at p.322 in the snoRNA binding domain (NOP domain). Conclusion This report is the first to associate PRPF31 gene's nonsense mutation and adRP and JMD. Our findings revealed that PRPF31 can lead to different clinical phenotypes in the same family, resulting either in adRP or syndrome of adRP and JMD. We believe our identification of the novel “A” insertion mutation in exon9 at chr19:54629961-54629961 in PRPF31 can provide further genetic evidence for clinical test for adRP and JMD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here